Rhythm Pharmaceuticals Inc’s recent filing unveils that its Chief Human Resources Officer Cramer Pamela J. unloaded Company’s shares for reported $0.3 million on Nov 07 ’24. In the deal valued at $65.00 per share,4,688 shares were sold. As a result of this transaction, Cramer Pamela J. now holds 13,500 shares worth roughly $0.89 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cramer Pamela J. sold 4,687 shares, generating $281,220 in total proceeds. Upon selling the shares at $60.00, the Chief Human Resources Officer now owns 13,500 shares.
Before that, PAMELA CRAMER bought 4,688 shares. Rhythm Pharmaceuticals Inc shares valued at $293,703 were divested by the Officer at a price of $62.65 per share.
Guggenheim initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on October 21, 2024; the price target was $70. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. JMP Securities began covering RYTM with “Mkt outperform” recommendation on September 17, 2024. BofA Securities revised its rating on May 08, 2024. It rated RYTM as “a Neutral” which previously was an “a Buy”.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -2.60% to $65.58. Over the last five days, the stock has gained 23.76%. Rhythm Pharmaceuticals Inc shares have risen nearly 42.66% since the year began. Nevertheless, the stocks have risen 143.43% over the past one year. While a 52-week high of $67.61 was reached on 11/11/24, a 52-week low of $26.55 was recorded on 05/29/24. SMA at 50 days reached $51.37, while 200 days put it at $45.21.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 64.31, which if violated will result in even more drops to 63.03. On the upside, there is a resistance level at 67.72. A further resistance level may holdings at 69.85. The Relative Strength Index (RSI) on the 14-day chart is 75.47, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 11.23, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.31%. Stochastics %K at 92.41% indicates the stock is a selling.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2024-10-15, dropping by -0.88 million shares to a total of 8.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 9.34 million shares. There was a decline of -10.41%, which implies that there is a negative sentiment for the stock.
